[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_15802 

# __Ineffective cure or treatment for covid-19__

## Articles mentionning the risk

* [Rezaei_deepsocial_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_593.md)

## Mitigations of this risk

* [Accelerated research for medications and vaccines, development of effective treatment protocols](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_17743.md)

## Name of the risk

Continued spread of the virus and high infection rates

## People affected by this risk

* [Global population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_278.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)

## Stakeholders who can mitigate this risk

* [Government agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_55.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Antiviral medications](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_835.md)
* [Research and testing facilities](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_14133.md)
* [Vaccine development](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_18121.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

